0001567619-18-008701.txt : 20181226 0001567619-18-008701.hdr.sgml : 20181226 20181226191525 ACCESSION NUMBER: 0001567619-18-008701 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181220 FILED AS OF DATE: 20181226 DATE AS OF CHANGE: 20181226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cordani David CENTRAL INDEX KEY: 0001318751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 181253530 MAIL ADDRESS: STREET 1: CIGNA CORPORATION STREET 2: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Corp CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 4 1 doc1.xml FORM 4 X0306 4 2018-12-20 0 0001739940 Cigna Corp CI 0001318751 Cordani David 900 COTTAGE GROVE RD BLOOMFIELD CT 06002 1 1 0 0 President and CEO Common Stock, $0.01 Par Value 2018-12-20 4 A 0 305006 0 A 305006 D Common Stock, $0.01 Par Value 2018-12-20 4 A 0 1640.1881 0 A 1640.1881 I By 401(k) Employee Stock Option (Right to Buy) 42.19 2018-12-20 4 A 0 189610 A 2021-03-01 Common Stock, $0.01 Par Value 189610 189610 D Employee Stock Option (Right to Buy) 44.425 2018-12-20 4 A 0 200229 A 2022-02-28 Common Stock, $0.01 Par Value 200229 200229 D Employee Stock Option (Right to Buy) 58.730 2018-12-20 4 A 0 206843 A 2023-03-05 Common Stock, $0.01 Par Value 206843 206843 D Employee Stock Option (Right to Buy) 78.035 2018-12-20 4 A 0 229443 A 2024-02-06 Common Stock, $0.01 Par Value 229443 229443 D Employee Stock Option (Right to Buy) 120.895 2018-12-20 4 A 0 159388 A 2025-02-25 Common Stock, $0.01 Par Value 159388 159388 D Employee Stock Option (Right to Buy) 139.22 2018-12-20 4 A 0 142801 A 2026-03-01 Common Stock, $0.01 Par Value 142801 142801 D Employee Stock Option (Right to Buy) 149.135 2018-12-20 4 A 0 119053 A 2027-02-28 Common Stock, $0.01 Par Value 119053 119053 D Employee Stock Option (Right to Buy) 197.35 2018-12-20 4 A 0 93490 A 2028-02-28 Common Stock, $0.01 Par Value 93490 93490 D Phantom Stock Units 2018-12-20 4 A 0 3120.6468 A Common Stock, $0.01 Par Value 3120.6486 3120.6486 D Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. ("New Cigna"), was acquired pursuant to the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. Represents shares acquired through ongoing participation in Cigna's 401(k) Plan and converted into an equivalent number of shares of New Cigna's Common Stock in connection with the Merger. This option was fully vested and exercisable at the time of the Merger. In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option. Two-thirds of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $139.22 per share, with the remaining one-third of the option vesting on March 1, 2019. One-third of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $149.135 per share, with the remaining two-thirds of the option vesting in two equal installments on February 28, 2019 and February 28, 2020. This option, which would have vested in three equal installments beginning on February 28, 2019, was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $197.35 per share on the same vesting terms. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. /s/ Jill M. Stadelman, attorney-in-fact 2018-12-26